Pharmaceuticals

Global eterinary Vaccines Sales Market Report 2016

  • QYR682216
  • 128 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of eterinary Vaccines

Revenue, means the sales value of eterinary Vaccines

This report studies sales (consumption) of eterinary Vaccines in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

GE Healthcare

Bayer Healthcare

Boehringer Ingelheim

Ceva Animal Health

Elanco Animal Health (Eli Lilly)

Heska Corporation

Merck Animal Healthcare

Merial Inc. (SANOFI)

Virbac

Zoetis

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of eterinary Vaccines in these regions, from 2011 to 2021 (forecast), like

USA

China

Europe

Japan

India

Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

Companion Animal Vaccines

Livestock Vaccines

Poultry Vaccines

Porcine Vaccines

Equine Vaccines

Aquaculture Vaccines

Other Animal Vaccines

Split by applications, this report focuses on sales, market share and growth rate of eterinary Vaccines in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global eterinary Vaccines Sales Market Report 2016

1 eterinary Vaccines Overview

1.1 Product Overview and Scope of eterinary Vaccines

1.2 Classification of eterinary Vaccines

1.2.1 Companion Animal Vaccines

1.2.2 Livestock Vaccines

1.2.3 Poultry Vaccines

1.2.4 Porcine Vaccines

1.2.5 Equine Vaccines

1.2.6 Aquaculture Vaccines

1.2.7 Other Animal Vaccines

1.3 Application of eterinary Vaccines

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 eterinary Vaccines Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of eterinary Vaccines (2011-2021)

1.5.1 Global eterinary Vaccines Sales and Growth Rate (2011-2021)

1.5.2 Global eterinary Vaccines Revenue and Growth Rate (2011-2021)

2 Global eterinary Vaccines Competition by Manufacturers, Type and Application

2.1 Global eterinary Vaccines Market Competition by Manufacturers

2.1.1 Global eterinary Vaccines Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global eterinary Vaccines Revenue and Share by Manufacturers (2011-2016)

2.2 Global eterinary Vaccines (Volume and Value) by Type

2.2.1 Global eterinary Vaccines Sales and Market Share by Type (2011-2016)

2.2.2 Global eterinary Vaccines Revenue and Market Share by Type (2011-2016)

2.3 Global eterinary Vaccines (Volume and Value) by Regions

2.3.1 Global eterinary Vaccines Sales and Market Share by Regions (2011-2016)

2.3.2 Global eterinary Vaccines Revenue and Market Share by Regions (2011-2016)

2.4 Global eterinary Vaccines (Volume) by Application

3 USA eterinary Vaccines (Volume, Value and Sales Price)

3.1 USA eterinary Vaccines Sales and Value (2011-2016)

3.1.1 USA eterinary Vaccines Sales and Growth Rate (2011-2016)

3.1.2 USA eterinary Vaccines Revenue and Growth Rate (2011-2016)

3.1.3 USA eterinary Vaccines Sales Price Trend (2011-2016)

3.2 USA eterinary Vaccines Sales and Market Share by Manufacturers

3.3 USA eterinary Vaccines Sales and Market Share by Type

3.4 USA eterinary Vaccines Sales and Market Share by Application

4 China eterinary Vaccines (Volume, Value and Sales Price)

4.1 China eterinary Vaccines Sales and Value (2011-2016)

4.1.1 China eterinary Vaccines Sales and Growth Rate (2011-2016)

4.1.2 China eterinary Vaccines Revenue and Growth Rate (2011-2016)

4.1.3 China eterinary Vaccines Sales Price Trend (2011-2016)

4.2 China eterinary Vaccines Sales and Market Share by Manufacturers

4.3 China eterinary Vaccines Sales and Market Share by Type

4.4 China eterinary Vaccines Sales and Market Share by Application

5 Europe eterinary Vaccines (Volume, Value and Sales Price)

5.1 Europe eterinary Vaccines Sales and Value (2011-2016)

5.1.1 Europe eterinary Vaccines Sales and Growth Rate (2011-2016)

5.1.2 Europe eterinary Vaccines Revenue and Growth Rate (2011-2016)

5.1.3 Europe eterinary Vaccines Sales Price Trend (2011-2016)

5.2 Europe eterinary Vaccines Sales and Market Share by Manufacturers

5.3 Europe eterinary Vaccines Sales and Market Share by Type

5.4 Europe eterinary Vaccines Sales and Market Share by Application

6 Japan eterinary Vaccines (Volume, Value and Sales Price)

6.1 Japan eterinary Vaccines Sales and Value (2011-2016)

6.1.1 Japan eterinary Vaccines Sales and Growth Rate (2011-2016)

6.1.2 Japan eterinary Vaccines Revenue and Growth Rate (2011-2016)

6.1.3 Japan eterinary Vaccines Sales Price Trend (2011-2016)

6.2 Japan eterinary Vaccines Sales and Market Share by Manufacturers

6.3 Japan eterinary Vaccines Sales and Market Share by Type

6.4 Japan eterinary Vaccines Sales and Market Share by Application

7 India eterinary Vaccines (Volume, Value and Sales Price)

7.1 India eterinary Vaccines Sales and Value (2011-2016)

7.1.1 India eterinary Vaccines Sales and Growth Rate (2011-2016)

7.1.2 India eterinary Vaccines Revenue and Growth Rate (2011-2016)

7.1.3 India eterinary Vaccines Sales Price Trend (2011-2016)

7.2 India eterinary Vaccines Sales and Market Share by Manufacturers

7.3 India eterinary Vaccines Sales and Market Share by Type

7.4 India eterinary Vaccines Sales and Market Share by Application

8 Southeast Asia eterinary Vaccines (Volume, Value and Sales Price)

8.1 Southeast Asia eterinary Vaccines Sales and Value (2011-2016)

8.1.1 Southeast Asia eterinary Vaccines Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia eterinary Vaccines Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia eterinary Vaccines Sales Price Trend (2011-2016)

8.2 Southeast Asia eterinary Vaccines Sales and Market Share by Manufacturers

8.3 Southeast Asia eterinary Vaccines Sales and Market Share by Type

8.4 Southeast Asia eterinary Vaccines Sales and Market Share by Application

9 Global eterinary Vaccines Manufacturers Analysis

9.1 GE Healthcare

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 eterinary Vaccines Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Bayer Healthcare

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 128 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Boehringer Ingelheim

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 145 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 Ceva Animal Health

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Sept Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Elanco Animal Health (Eli Lilly)

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Heska Corporation

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Merck Animal Healthcare

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 Merial Inc. (SANOFI)

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Virbac

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 Zoetis

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Zoetis eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

10 eterinary Vaccines Maufacturing Cost Analysis

10.1 eterinary Vaccines Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of eterinary Vaccines

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 eterinary Vaccines Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global eterinary Vaccines Market Forecast (2016-2021)

14.1 Global eterinary Vaccines Sales, Revenue Forecast (2016-2021)

14.2 Global eterinary Vaccines Sales Forecast by Regions (2016-2021)

14.3 Global eterinary Vaccines Sales Forecast by Type (2016-2021)

14.4 Global eterinary Vaccines Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of eterinary Vaccines

Table Classification of eterinary Vaccines

Figure Global Sales Market Share of eterinary Vaccines by Type in 2015

Figure Companion Animal Vaccines Picture

Figure Livestock Vaccines Picture

Figure Poultry Vaccines Picture

Figure Porcine Vaccines Picture

Figure Equine Vaccines Picture

Figure Aquaculture Vaccines Picture

Figure Other Animal Vaccines Picture

Table Applications of eterinary Vaccines

Figure Global Sales Market Share of eterinary Vaccines by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA eterinary Vaccines Revenue and Growth Rate (2011-2021)

Figure China eterinary Vaccines Revenue and Growth Rate (2011-2021)

Figure Europe eterinary Vaccines Revenue and Growth Rate (2011-2021)

Figure Japan eterinary Vaccines Revenue and Growth Rate (2011-2021)

Figure India eterinary Vaccines Revenue and Growth Rate (2011-2021)

Figure Southeast Asia eterinary Vaccines Revenue and Growth Rate (2011-2021)

Figure Global eterinary Vaccines Sales and Growth Rate (2011-2021)

Figure Global eterinary Vaccines Revenue and Growth Rate (2011-2021)

Table Global eterinary Vaccines Sales of Key Manufacturers (2011-2016)

Table Global eterinary Vaccines Sales Share by Manufacturers (2011-2016)

Figure 2015 eterinary Vaccines Sales Share by Manufacturers

Figure 2016 eterinary Vaccines Sales Share by Manufacturers

Table Global eterinary Vaccines Revenue by Manufacturers (2011-2016)

Table Global eterinary Vaccines Revenue Share by Manufacturers (2011-2016)

Table 2015 Global eterinary Vaccines Revenue Share by Manufacturers

Table 2016 Global eterinary Vaccines Revenue Share by Manufacturers

Table Global eterinary Vaccines Sales and Market Share by Type (2011-2016)

Table Global eterinary Vaccines Sales Share by Type (2011-2016)

Figure Sales Market Share of eterinary Vaccines by Type (2011-2016)

Figure Global eterinary Vaccines Sales Growth Rate by Type (2011-2016)

Table Global eterinary Vaccines Revenue and Market Share by Type (2011-2016)

Table Global eterinary Vaccines Revenue Share by Type (2011-2016)

Figure Revenue Market Share of eterinary Vaccines by Type (2011-2016)

Figure Global eterinary Vaccines Revenue Growth Rate by Type (2011-2016)

Table Global eterinary Vaccines Sales and Market Share by Regions (2011-2016)

Table Global eterinary Vaccines Sales Share by Regions (2011-2016)

Figure Sales Market Share of eterinary Vaccines by Regions (2011-2016)

Figure Global eterinary Vaccines Sales Growth Rate by Regions (2011-2016)

Table Global eterinary Vaccines Revenue and Market Share by Regions (2011-2016)

Table Global eterinary Vaccines Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of eterinary Vaccines by Regions (2011-2016)

Figure Global eterinary Vaccines Revenue Growth Rate by Regions (2011-2016)

Table Global eterinary Vaccines Sales and Market Share by Application (2011-2016)

Table Global eterinary Vaccines Sales Share by Application (2011-2016)

Figure Sales Market Share of eterinary Vaccines by Application (2011-2016)

Figure Global eterinary Vaccines Sales Growth Rate by Application (2011-2016)

Figure USA eterinary Vaccines Sales and Growth Rate (2011-2016)

Figure USA eterinary Vaccines Revenue and Growth Rate (2011-2016)

Figure USA eterinary Vaccines Sales Price Trend (2011-2016)

Table USA eterinary Vaccines Sales by Manufacturers (2011-2016)

Table USA eterinary Vaccines Market Share by Manufacturers (2011-2016)

Table USA eterinary Vaccines Sales by Type (2011-2016)

Table USA eterinary Vaccines Market Share by Type (2011-2016)

Table USA eterinary Vaccines Sales by Application (2011-2016)

Table USA eterinary Vaccines Market Share by Application (2011-2016)

Figure China eterinary Vaccines Sales and Growth Rate (2011-2016)

Figure China eterinary Vaccines Revenue and Growth Rate (2011-2016)

Figure China eterinary Vaccines Sales Price Trend (2011-2016)

Table China eterinary Vaccines Sales by Manufacturers (2011-2016)

Table China eterinary Vaccines Market Share by Manufacturers (2011-2016)

Table China eterinary Vaccines Sales by Type (2011-2016)

Table China eterinary Vaccines Market Share by Type (2011-2016)

Table China eterinary Vaccines Sales by Application (2011-2016)

Table China eterinary Vaccines Market Share by Application (2011-2016)

Figure Europe eterinary Vaccines Sales and Growth Rate (2011-2016)

Figure Europe eterinary Vaccines Revenue and Growth Rate (2011-2016)

Figure Europe eterinary Vaccines Sales Price Trend (2011-2016)

Table Europe eterinary Vaccines Sales by Manufacturers (2011-2016)

Table Europe eterinary Vaccines Market Share by Manufacturers (2011-2016)

Table Europe eterinary Vaccines Sales by Type (2011-2016)

Table Europe eterinary Vaccines Market Share by Type (2011-2016)

Table Europe eterinary Vaccines Sales by Application (2011-2016)

Table Europe eterinary Vaccines Market Share by Application (2011-2016)

Figure Japan eterinary Vaccines Sales and Growth Rate (2011-2016)

Figure Japan eterinary Vaccines Revenue and Growth Rate (2011-2016)

Figure Japan eterinary Vaccines Sales Price Trend (2011-2016)

Table Japan eterinary Vaccines Sales by Manufacturers (2011-2016)

Table Japan eterinary Vaccines Market Share by Manufacturers (2011-2016)

Table Japan eterinary Vaccines Sales by Type (2011-2016)

Table Japan eterinary Vaccines Market Share by Type (2011-2016)

Table Japan eterinary Vaccines Sales by Application (2011-2016)

Table Japan eterinary Vaccines Market Share by Application (2011-2016)

Figure India eterinary Vaccines Sales and Growth Rate (2011-2016)

Figure India eterinary Vaccines Revenue and Growth Rate (2011-2016)

Figure India eterinary Vaccines Sales Price Trend (2011-2016)

Table India eterinary Vaccines Sales by Manufacturers (2011-2016)

Table India eterinary Vaccines Market Share by Manufacturers (2011-2016)

Table India eterinary Vaccines Sales by Type (2011-2016)

Table India eterinary Vaccines Market Share by Type (2011-2016)

Table India eterinary Vaccines Sales by Application (2011-2016)

Table India eterinary Vaccines Market Share by Application (2011-2016)

Figure Southeast Asia eterinary Vaccines Sales and Growth Rate (2011-2016)

Figure Southeast Asia eterinary Vaccines Revenue and Growth Rate (2011-2016)

Figure Southeast Asia eterinary Vaccines Sales Price Trend (2011-2016)

Table Southeast Asia eterinary Vaccines Sales by Manufacturers (2011-2016)

Table Southeast Asia eterinary Vaccines Market Share by Manufacturers (2011-2016)

Table Southeast Asia eterinary Vaccines Sales by Type (2011-2016)

Table Southeast Asia eterinary Vaccines Market Share by Type (2011-2016)

Table Southeast Asia eterinary Vaccines Sales by Application (2011-2016)

Table Southeast Asia eterinary Vaccines Market Share by Application (2011-2016)

Table GE Healthcare Basic Information List

Table GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GE Healthcare eterinary Vaccines Global Market Share (2011-2016)

Table Bayer Healthcare Basic Information List

Table Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer Healthcare eterinary Vaccines Global Market Share (2011-2016)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Boehringer Ingelheim eterinary Vaccines Global Market Share (2011-2016)

Table Ceva Animal Health Basic Information List

Table Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Ceva Animal Health eterinary Vaccines Global Market Share (2011-2016)

Table Elanco Animal Health (Eli Lilly) Basic Information List

Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Elanco Animal Health (Eli Lilly) eterinary Vaccines Global Market Share (2011-2016)

Table Heska Corporation Basic Information List

Table Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Heska Corporation eterinary Vaccines Global Market Share (2011-2016)

Table Merck Animal Healthcare Basic Information List

Table Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Merck Animal Healthcare eterinary Vaccines Global Market Share (2011-2016)

Table Merial Inc. (SANOFI) Basic Information List

Table Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Merial Inc. (SANOFI) eterinary Vaccines Global Market Share (2011-2016)

Table Virbac Basic Information List

Table Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Virbac eterinary Vaccines Global Market Share (2011-2016)

Table Zoetis Basic Information List

Table Zoetis eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Zoetis eterinary Vaccines Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of eterinary Vaccines

Figure Manufacturing Process Analysis of eterinary Vaccines

Figure eterinary Vaccines Industrial Chain Analysis

Table Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015

Table Major Buyers of eterinary Vaccines

Table Distributors/Traders List

Figure Global eterinary Vaccines Sales and Growth Rate Forecast (2016-2021)

Figure Global eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)

Table Global eterinary Vaccines Sales Forecast by Regions (2016-2021)

Table Global eterinary Vaccines Sales Forecast by Type (2016-2021)

Table Global eterinary Vaccines Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370